CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,387,000 | -20.7% | 30,500 | -7.9% | 0.60% | -8.0% |
| Q1 2018 | $1,748,000 | -62.0% | 33,100 | -51.1% | 0.65% | -53.6% |
| Q4 2017 | $4,600,000 | -1.6% | 67,650 | +19.2% | 1.41% | -0.8% |
| Q3 2017 | $4,676,000 | +57.8% | 56,750 | +79.3% | 1.42% | +69.1% |
| Q2 2017 | $2,963,000 | +46.1% | 31,650 | -0.6% | 0.84% | +28.5% |
| Q1 2017 | $2,028,000 | +148.2% | 31,850 | +73.1% | 0.65% | +92.9% |
| Q4 2016 | $817,000 | +173.2% | 18,400 | +121.7% | 0.34% | +204.5% |
| Q3 2016 | $299,000 | – | 8,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |